ja_mageia

For the second year in a row, the Children's Tumor Foundation will be among a small group of foundations invited to speak at the Biotechnology Industry Organization CEO and Investors Conference to be held Feb 14-15 in New York.   The BIO conference is a forum for emerging biotech companies to meet investors and form partnerships with larger pharmaceutical companies; for CTF, it is a valuable opportunity to present the pipeline of candidate neurofibromatosis drugs currently in preclinical testing and clinical trials, and to engage new industry partners who have drugs that could be future neurofibromatosis treatments.  Foundation Chief Scientific Officer Dr. Kim Hunter-Schaedle will present. This terrific opportunity builds on CTF's recent invited presentation at the Milken Institute's  Partnering for Cures conference which can be viewed here.